Literature DB >> 19641462

Oximetry, heart rate variability, and the diagnosis of mild-to-moderate acute mountain sickness.

Michael S Koehle1, Jordan A Guenette, Darren E R Warburton.   

Abstract

The clinical evaluation of acute mountain sickness (AMS) is often performed in remote settings with minimal equipment. The purpose of this study was to examine the utility of heart rate variability and other cardiovascular parameters in a high-altitude clinical setting. Forty-one participants were recruited from the patient population of the clinic, and from festivalgoers [those who attended the Janai Purnima festival held at Lake Gosainkunda (4380 m) in Langtang, Nepal] in the vicinity of the clinic. Twenty-one participants were diagnosed with AMS; remaining participants were free from altitude illness. Heart rate variability (both time and frequency domain measures), arterial oxygen saturation (SpO2), blood pressure and Lake Louise Score were evaluated in all the participants. Oxygen saturation and diastolic blood pressure were negatively and positively correlated with Lake Louise Score, respectively. Receiver operating characteristic analysis indicated that an SpO2 of 86% or greater was associated with a very low likelihood of AMS at this altitude. No heart rate variability parameters were different in the AMS group as compared with the control group. In conclusion, in patients with SpO2 of 86% or more at 4380 m or higher, the likelihood of AMS is low. Diastolic blood pressure correlated with AMS severity, whereas heart rate variability was not useful in the diagnosis of AMS.

Entities:  

Mesh:

Year:  2010        PMID: 19641462     DOI: 10.1097/MEJ.0b013e32832fa099

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  15 in total

Review 1.  High altitude pilgrimage medicine.

Authors:  Buddha Basnyat
Journal:  High Alt Med Biol       Date:  2014-12       Impact factor: 1.981

2.  Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude?

Authors:  Veronika Leichtfried; Daniel Basic; Martin Burtscher; Raffaella Matteucci Gothe; Uwe Siebert; Wolfgang Schobersberger
Journal:  Sleep Breath       Date:  2015-06-02       Impact factor: 2.816

3.  Hemodynamic characteristics of high-altitude headache following acute high altitude exposure at 3700 m in young Chinese men.

Authors:  Shi-Zhu Bian; Jun Jin; Qian-Ning Li; Jie Yu; Cai-Fa Tang; Rong-Sheng Rao; Shi-Yong Yu; Xiao-Hui Zhao; Jun Qin; Lan Huang
Journal:  J Headache Pain       Date:  2015-05-12       Impact factor: 7.277

4.  Autonomic cardiovascular responses in acclimatized lowlanders on prolonged stay at high altitude: a longitudinal follow up study.

Authors:  Priyanka Dhar; Vijay K Sharma; Kalpana B Hota; Saroj K Das; Sunil K Hota; Ravi B Srivastava; Shashi B Singh
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

Review 5.  Non-high altitude methods for rapid screening of susceptibility to acute mountain sickness.

Authors:  Han Song; Tao Ke; Wen-Jing Luo; Jing-Yuan Chen
Journal:  BMC Public Health       Date:  2013-09-30       Impact factor: 3.295

6.  Benzolamide improves oxygenation and reduces acute mountain sickness during a high-altitude trek and has fewer side effects than acetazolamide at sea level.

Authors:  David J Collier; Chris B Wolff; Anne-Marie Hedges; John Nathan; Rod J Flower; James S Milledge; Erik R Swenson
Journal:  Pharmacol Res Perspect       Date:  2016-05-19

7.  Heart rate variability changes at 2400 m altitude predicts acute mountain sickness on further ascent at 3000-4300 m altitudes.

Authors:  Heikki M Karinen; Arja Uusitalo; Henri Vähä-Ypyä; Mika Kähönen; Juha E Peltonen; Phyllis K Stein; Jari Viik; Heikki O Tikkanen
Journal:  Front Physiol       Date:  2012-08-30       Impact factor: 4.566

8.  A specific objective supplemental factor in evaluating acute mountain sickness: ΔHR in combination with SaO2.

Authors:  Ming Li; Ji-Hang Zhang; Guo-Xi Zhao; Shi-Zhu Bian; Xu-Bin Gao; Xi Liu; Jie Yu; Jun-Qing Dong; Guo-Zhu Chen; Hong Wang; Lan Huang
Journal:  Mil Med Res       Date:  2015-10-26

9.  A prospective epidemiological study of acute mountain sickness in Nepalese pilgrims ascending to high altitude (4380 m).

Authors:  Martin J MacInnis; Eric A Carter; Michael G Freeman; Bidur Prasad Pandit; Ashmita Siwakoti; Ankita Subedi; Utsav Timalsina; Nadia Widmer; Ghan Bahadur Thapa; Michael S Koehle; Jim L Rupert
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

10.  Principal Component Analysis and Risk Factors for Acute Mountain Sickness upon Acute Exposure at 3700 m.

Authors:  Shi-Zhu Bian; Jun Jin; Ji-Hang Zhang; Qian-Ning Li; Jie Yu; Shi-Yong Yu; Jian-Fei Chen; Xue-Jun Yu; Jun Qin; Lan Huang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.